Comprehensive Analysis of Pyroptosis-Related Long Noncoding RNA Immune Infiltration and Prediction of Prognosis in Patients with Colon Cancer

Figure 2

Clinical and pathological characteristics, overall survival and association of immune checkpoint inhibitors of colon cancer patients in Clusters 1 and 2. (a) Consensus clustering matrix for k = 2, (b) heatmap and clinicopathologic features of Clusters 1 and 2, (c) Kaplan–Meier curves of overall survival (OS) of Clusters 1 and 2, (d) PD-1 expression levels of Clusters 1 and 2, (e) PD-1 expression levels in normal sample and tumour sample, (f) PD-L1 expression levels of Clusters 1 and 2, (g) PD-L1 expression levels in normal and tumour sample, (h) CTLA-4 expression levels of Clusters 1 and 2, (i) CTLA-4 expression levels in normal and tumour sample, (j) correlation between PD-1 expression level and differential expression of pyroptosis-related lncRNAs, (k) correlation between PD-L1 expression level and differential expression of pyroptosis-related lncRNAs, and (l) correlation between CTLA-4 expression level and differential expression of pyroptosis-related lncRNAs. , , and .

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

(k)

(l)